vs
BioNTech SE（BNTX）与亨斯迈（HUN）财务数据对比。点击上方公司名可切换其他公司
BioNTech SE的季度营收约是亨斯迈的1.1倍（$1.5B vs $1.4B），BioNTech SE净利率更高（-1.9% vs -7.1%，领先5.2%）
BioNTech SE是总部位于德国美因茨的跨国生物技术企业，专注于免疫疗法及疫苗研发工作，核心研究方向覆盖肿瘤、传染性疾病等医疗领域，相关技术处于全球生物医药行业领先水平。
亨斯迈公司是总部位于美国得克萨斯州伍德兰兹的全球化化工巨头，面向消费端与工业客户生产、销售各类化工产品，主营聚氨酯、高性能材料及胶粘剂，客户覆盖宝马、通用电气、雪佛龙、宝洁、联合利华等知名品牌。目前公司在全球25个国家设有60余处生产、研发及运营基地，员工约7000人。
BNTX vs HUN — 直观对比
营收规模更大
BNTX
是对方的1.1倍
$1.4B
净利率更高
BNTX
高出5.2%
-7.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.4B |
| 净利润 | $-28.7M | $-96.0M |
| 毛利率 | — | 12.1% |
| 营业利润率 | -3.1% | -4.4% |
| 净利率 | -1.9% | -7.1% |
| 营收同比 | — | -6.7% |
| 净利润同比 | — | 31.9% |
| 每股收益（稀释后） | — | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNTXHUN
| Q4 25 | — | $1.4B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $260.8M | $1.5B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | — | $1.6B | ||
| Q1 24 | — | $1.5B |
净利润BNTXHUN
| Q4 25 | — | $-96.0M | ||
| Q3 25 | $-28.7M | $-25.0M | ||
| Q2 25 | $-386.6M | $-158.0M | ||
| Q1 25 | — | $-5.0M | ||
| Q4 24 | — | $-141.0M | ||
| Q3 24 | $198.1M | $-33.0M | ||
| Q2 24 | — | $22.0M | ||
| Q1 24 | — | $-37.0M |
毛利率BNTXHUN
| Q4 25 | — | 12.1% | ||
| Q3 25 | — | 14.0% | ||
| Q2 25 | — | 12.5% | ||
| Q1 25 | — | 14.3% | ||
| Q4 24 | — | 12.9% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 15.4% | ||
| Q1 24 | — | 13.7% |
营业利润率BNTXHUN
| Q4 25 | — | -4.4% | ||
| Q3 25 | -3.1% | 0.4% | ||
| Q2 25 | -192.1% | -8.2% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | -4.3% | ||
| Q3 24 | 0.8% | 2.7% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | -2.6% |
净利率BNTXHUN
| Q4 25 | — | -7.1% | ||
| Q3 25 | -1.9% | -1.7% | ||
| Q2 25 | -148.2% | -10.8% | ||
| Q1 25 | — | -0.4% | ||
| Q4 24 | — | -9.7% | ||
| Q3 24 | 15.9% | -2.1% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | -2.5% |
每股收益（稀释后）BNTXHUN
| Q4 25 | — | $-0.56 | ||
| Q3 25 | — | $-0.14 | ||
| Q2 25 | — | $-0.92 | ||
| Q1 25 | — | $-0.03 | ||
| Q4 24 | — | $-0.82 | ||
| Q3 24 | — | $-0.19 | ||
| Q2 24 | — | $0.13 | ||
| Q1 24 | — | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $429.0M |
| 总债务越低越好 | — | $2.0B |
| 股东权益账面价值 | — | $2.8B |
| 总资产 | — | $7.0B |
| 负债/权益比越低杠杆越低 | — | 0.73× |
8季度趋势，按日历期对齐
现金及短期投资BNTXHUN
| Q4 25 | — | $429.0M | ||
| Q3 25 | — | $468.0M | ||
| Q2 25 | — | $399.0M | ||
| Q1 25 | — | $334.0M | ||
| Q4 24 | — | $340.0M | ||
| Q3 24 | — | $330.0M | ||
| Q2 24 | — | $335.0M | ||
| Q1 24 | — | $552.0M |
总债务BNTXHUN
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $2.1B |
股东权益BNTXHUN
| Q4 25 | — | $2.8B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.1B | ||
| Q1 24 | — | $3.2B |
总资产BNTXHUN
| Q4 25 | — | $7.0B | ||
| Q3 25 | — | $7.1B | ||
| Q2 25 | — | $7.1B | ||
| Q1 25 | — | $7.2B | ||
| Q4 24 | — | $7.1B | ||
| Q3 24 | — | $7.3B | ||
| Q2 24 | — | $7.3B | ||
| Q1 24 | — | $7.6B |
负债/权益比BNTXHUN
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 0.73× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | 0.62× | ||
| Q1 24 | — | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $76.0M |
| 自由现金流经营现金流 - 资本支出 | — | $19.0M |
| 自由现金流率自由现金流/营收 | — | 1.4% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $116.0M |
8季度趋势，按日历期对齐
经营现金流BNTXHUN
| Q4 25 | — | $76.0M | ||
| Q3 25 | — | $196.0M | ||
| Q2 25 | — | $91.0M | ||
| Q1 25 | — | $-74.0M | ||
| Q4 24 | — | $153.0M | ||
| Q3 24 | — | $129.0M | ||
| Q2 24 | — | $46.0M | ||
| Q1 24 | — | $-65.0M |
自由现金流BNTXHUN
| Q4 25 | — | $19.0M | ||
| Q3 25 | — | $153.0M | ||
| Q2 25 | — | $54.0M | ||
| Q1 25 | — | $-110.0M | ||
| Q4 24 | — | $102.0M | ||
| Q3 24 | — | $88.0M | ||
| Q2 24 | — | $-4.0M | ||
| Q1 24 | — | $-107.0M |
自由现金流率BNTXHUN
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | -7.8% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | -0.3% | ||
| Q1 24 | — | -7.3% |
资本支出强度BNTXHUN
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.9% |
现金转化率BNTXHUN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.09× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BNTX
暂无分部数据
HUN
| Diversified | $897.0M | 66% |
| Specialty | $231.0M | 17% |
| Performance Products | $113.0M | 8% |
| Advanced Materials | $61.0M | 5% |
| Related Party Customers | $19.0M | 1% |
| Other | $12.0M | 1% |
